Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 21;18(1):44.
doi: 10.1186/s12943-019-1003-5.

Circular RNAs and their roles in head and neck cancers

Affiliations
Review

Circular RNAs and their roles in head and neck cancers

Yang Guo et al. Mol Cancer. .

Abstract

Circular RNAs are abundant endogenous non-coding RNA with no 5' cap and 3' polyadenylation tail that modify liner mRNAs and have no terminal structures. Our knowledge of the biogenesis of circular RNAs has been expanded, and circular RNAs were shown to be key regulators of various diseases, especially cancers. Head and neck cancers are the sixth most popular cancers worldwide, and the overall survival rates remain unsatisfactory. Recent studies have indicated that circular RNAs are involved in the tumorigenesis, progression, invasion and chemosensitivity of head and neck cancers and that some circular RNAs could serve as diagnostic and prognostic biomarkers. In this study, we summarize research advances in the regulation of circular RNA biogenesis, their characteristics and functions, the involvement of circular RNAs in the pathophysiology of head and neck cancers and their potential clinical utilization, as well as the likely directions of future studies.

Keywords: Biogenesis; Biomarker; Characteristics; Circular RNA; Head and neck cancer; Sponge function.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors have read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
The formation and classification of circRNAs. Canonical splicing produces liner mRNAs (a) while back-splicing generates circRNAs (b). b. CircRNAs were usually categorized into ecircRNAs, ciRNAs and EIciRNAs depending on their components, which were derived from exons and introns, and both of them in pre-mRNAs, respectively. Different ecircRNAs could be generated from one pre-mRNA via alternative splicing. The red segment and yellow segment between Exon 4 and Exon 5 represented a 7-nt GU-rich motif near the 5′ splice site and an 11-nt C-rich motif at the branchpoint site, respectively, which promoted the generation of ciRNAs
Fig. 2
Fig. 2
Three models for the biogenesis of ecircRNAs. a. Lariat-driven circularization, also known as the exon-skipping model. The remaining exons in the pre-mRNAs were allocated into the concomitant linear mRNAs. b. Intronic base pairing-driven circularization. The pairing across complement sequences in the flanking introns brought the splicing sites into proximity, facilitating the circularization of intervening exons. c. RBP-driven circularization. The interactions of RBPs binding to the flanking introns serve as a bridge to bring the introns into proximity, promoting the process of circularization. d, e. Some RBPs could bind to the intronic dsRNA to regulate the biogenesis of ecircRNAs. While some RBPs (such as NF90/NF110) stabilize the dsRNAs to promote the generation of ecircRNAs (d), some RBPs (such as DHX9 and ADAR1) destroy the stability of dsRNAs to suppress the generation of ecircRNAs (e)

Similar articles

Cited by

References

    1. Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2016;91(3):386–396. doi: 10.1016/j.mayocp.2015.12.017. - DOI - PubMed
    1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi: 10.3322/caac.21262. - DOI - PubMed
    1. Mifsud M, Eskander A, Irish J, Gullane P, Gilbert R, Brown D, de Almeida JR, Urbach DR, Goldstein DP. Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993-2010. Head Neck. 2017;39(9):1770–1778. doi: 10.1002/hed.24829. - DOI - PubMed
    1. Rettig EM, D'Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015;24(3):379–396. doi: 10.1016/j.soc.2015.03.001. - DOI - PubMed
    1. Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C, Buonaguro FM, Tornesello ML. Update on head and neck Cancer: current knowledge on epidemiology, risk factors, Molecular Features and Novel Therapies. Oncology. 2015;89(3):125–136. doi: 10.1159/000381717. - DOI - PubMed

Publication types